New 'Microbial' vaccine seeks to train immune system to fight lymphoma

NCT ID NCT04669171

Summary

This study is testing a new type of treatment called EO2463, which is a therapeutic vaccine designed to teach the body's immune system to recognize and attack lymphoma cells. It will be given to patients with slow-growing non-Hodgkin's lymphoma, both by itself and in combination with standard lymphoma drugs. The main goals are to find a safe and effective dose and to see if the treatment can shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU d'Amiens-Picardie - Hopital SUD

    RECRUITING

    Amiens, France

    Contact

  • Clinica Universidad de Navarra

    RECRUITING

    Madrid, Spain

    Contact

  • Clinica Universidad de Navarra

    RECRUITING

    Pamplona, Spain

    Contact

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

  • Hospital Clinico Universitario de Salamanca

    RECRUITING

    Salamanca, Spain

    Contact

  • IRCCS Policlinico San Matteo Foundation - University of Pavia

    RECRUITING

    Naples, Italy

    Contact

  • IRCCS Policlinico San Matteo Foundation - University of Pavia

    RECRUITING

    Pavia, Italy

    Contact

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

  • University Hospital Vall d'Hebron, Institute of Oncology

    RECRUITING

    Barcelona, Spain

    Contact

  • University of Bologna

    WITHDRAWN

    Bologna, Italy

  • University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center)

    RECRUITING

    Rochester, New York, 14642, United States

    Contact

  • University of Washington-Seattle Cancer Care Alliance

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact

Conditions

Explore the condition pages connected to this study.